摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2S,3R,4S)-N-tert-butyloxycarbonyl-3,4-dihydroxy-3,4-O-isopropylidene-proline | 117781-10-9

中文名称
——
中文别名
——
英文名称
(2S,3R,4S)-N-tert-butyloxycarbonyl-3,4-dihydroxy-3,4-O-isopropylidene-proline
英文别名
(2S,3R,4S)-N-(tert-butoxycarbonyl)-3,4-O-isopropylidene-3,4-dihydroxyproline;(2R,3R,4S)-N-tert-butoxycarbonyl-3,4-dihydroxyproline isopropylidene acetal;(2R,3R,4S)-N-(tert-butoxycarbonyl)-3,4-isopropylidenedioxyproline;(3AR,4S,6AS)-5-(Tert-butoxycarbonyl)-2,2-dimethyltetrahydro-4H-[1,3]dioxolo[4,5-C]pyrrole-4-carboxylic acid;(3aR,4S,6aS)-2,2-dimethyl-5-[(2-methylpropan-2-yl)oxycarbonyl]-3a,4,6,6a-tetrahydro-[1,3]dioxolo[4,5-c]pyrrole-4-carboxylic acid
(2S,3R,4S)-N-tert-butyloxycarbonyl-3,4-dihydroxy-3,4-O-isopropylidene-proline化学式
CAS
117781-10-9
化学式
C13H21NO6
mdl
——
分子量
287.313
InChiKey
FRDGVQODRPFOOR-CIUDSAMLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    407.8±45.0 °C(Predicted)
  • 密度:
    1.228±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.8
  • 重原子数:
    20
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.85
  • 拓扑面积:
    85.3
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Ring-Closing Metathesis of Chiral Allylamines. Enantioselective Synthesis of (2<i>S</i>,3<i>R</i>,4<i>S</i>)-3,4-Dihydroxyproline
    作者:Rubén Martín、Montserrat Alcón、Miquel A. Pericàs、Antoni Riera
    DOI:10.1021/jo025832p
    日期:2002.10.1
    The ring-closing metathesis (RCM) of two types of unsaturated chiral allylamines III, easily available from enantiomerically enriched epoxy alcohols, has been studied. Fully protected allylamines IIIa [(1)R = CH(2)-(CH(2))(n)()-CH=CH(2); (2)R = Boc; (3)R = PMB] have been prepared from unsaturated epoxy alcohols, whereas bis-allylamines IIIb ((1)R = Ph, (2)R = allyl,(3)R = Boc or PMB) have been prepared
    研究了两种容易从对映异构体富集的环氧醇中获得的不饱和手性烯丙胺III的闭环易位(RCM)。完全保护的烯丙胺IIIa [(1)R = CH(2)-(CH(2))(n)()-CH = CH(2); (2)R = Boc; (3)R = PMB]由不饱和环氧醇制备,而双烯丙基胺IIIb((1)R = Ph,(2)R =烯丙基,(3)R = Boc或PMB)已由2, 3-环氧-3-苯基丙醇。两种类型均已进行了RCM处理,以提供环状烯丙胺I或II。这些中间体的合成潜力已通过(2S,3R,4S)-3,4-二羟基脯氨酸的对映选择性合成得到证明。
  • Stereoselective Synthesis of (+)-1,8-Di-epi- and (-)-1-epi-Swainsonine from an (S)-Pyroglutamic Acid Derivative.
    作者:Nobuo IKOTA
    DOI:10.1248/cpb.41.1717
    日期:——
    (+)-1, 8-Di-epi-swainsonine (15) and (-)-1-epi-swainsonine (17) were synthesized stereoselectively from an (S)-pyroglutamic acid derivative (1a). A (2R, 3R, 4R)-3, 4-dihydroxy-2-hydroxymethylpyrrolidine derivative (6a) was prepared by cis-dihydroxylation of an α, β-unsaturated lactam (2) followed by epimerization of the di-O-benzyl derivative (3b) as the key reactions. The diastereoselective allylation of the aldehyde 6b obtained from 6a and subsequent cyclization of 13 and 16 gave 15 and 17, respectively. It proved that 1, 8-di-epi-swainsonine (15) is dextrorotatory.
    由(S)-焦谷氨酸衍生物(1a)立体选择性合成(+)-1, 8-二-表-苦马豆素(15)和(-)-1-表-苦马豆素(17)。 (2R, 3R, 4R)-3, 4-二羟基-2-羟甲基吡咯烷衍生物 (6a) 通过 α, β-不饱和内酰胺 (2) 的顺式二羟基化和二-O-苄基衍生物的差向异构化制备(3b)为关键反应。由6a获得的醛6b的非对映选择性烯丙基化以及随后13和16的环化分别得到15和17。证明1, 8-二-表-苦豆素(15)具有右旋性。
  • Total synthesis of both enantiomers of trans-2,3-cis-3,4-dihydroxyproline
    作者:Franca Zanardi、Lucia Battistini、Marika Nespi、Gloria Rassu、Pietro Spanu、Mara Cornia、Giovanni Casiraghi
    DOI:10.1016/0957-4166(96)00123-1
    日期:1996.4
    Both enantiomers of trans-2,3-cis-3,4-dihydroxyproline, 4 and 5, have been stereoselectively synthesized from 2,3-O-isopropylidene-D-glyceraldehyde 1, by taking advantage of a divergent and parallel synthetic strategy, utilizing N-(tert-butoxycarbonyl)-2-(tert-butyldimethylsiloxy)pyrrole (TBSOP) as the common four-carbon synthon. Copyright (C) 1996 Elsevier Science Ltd
  • Stereospecific Cyclization Strategies for α,ε-Dihydroxy-β-amino Esters: Asymmetric Syntheses of Imino and Amino Sugars
    作者:Stephen G. Davies、Emma M. Foster、James A. Lee、Paul M. Roberts、James E. Thomson
    DOI:10.1021/jo5018298
    日期:2014.10.17
    A range of biologically significant imino and amino sugars [1,4-dideoxy-1,4-imino-D-allitol, 3,6-dideoxy-3,6-imino-L-allonic acid, (3R,4S)-3,4-dihydroxy-L-proline, 1,5-anhydro-4-deoxy-4-amino-D-glucitol, and 1,5-anhydro-4-deoxy-4-amino-L-iditol] has been prepared via stereospecific cyclization of alpha,epsilon-dihydroxy-beta-amino esters. These substrates are readily prepared via conjugate addition of lithium (S)-N-benzyl-N-(alpha-methylbenzyl)amide to enantiopure alpha,beta-unsaturated esters (beta-substituted with cis- and trans-dioxolane units) coupled with in situ enolate oxidation with camphorsulfonyloxaziridine (CSO). Activation of the epsilon-hydroxyl group allowed cyclization to either the corresponding pyrrolidine or the tetrahydropyran scaffold, with the course of the cyclization process being dictated by the relative configuration of the dioxolane unit. When the alpha,epsilon-dihydroxy-beta-amino ester bears a cis-dioxolane unit, cyclization occurs upon attack of the beta-amino substituent to give the corresponding pyrrolidine after in situ N-debenzylation. In contrast, when the alpha,epsilon-dihydroxy-beta-amino ester bears a trans-dioxolane unit, cyclization occurs upon attack of the alpha-hydroxyl substituent to give the corresponding tetrahydropyran.
  • FLEET, GEORGE W. J.;SON, JONG CHAN, TETRAHEDRON, 44,(1988) N 9, C. 2637-2647
    作者:FLEET, GEORGE W. J.、SON, JONG CHAN
    DOI:——
    日期:——
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物